1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

  • February 2018
  • 87 pages
  • ID: 5336312
  • Format: PDF
  • By Frost & Sullivan

Summary

Table of Contents

Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows

The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe.

Increasing clinical trial activities in the emerging Asia-Pacific markets and recent favorable regulatory reforms (China to accept overseas trial data; Indian government allowing? academic institutions to take Drug Controller General of India (DCGI) permission) are expected to drive the demand for clinical trial IT solutions from 2017 to 2020.

Clinical trial data management (CTDM) and emerging eClinical solutions comprising electronic data capture (EDC), clinical data management systems (CDMS), clinical trial management systems (CTMS), randomization and trial supply management systems (RTMS), electronic clinical outcome assessment (eCOA), trail planning and safety solutions, clinical data integration platforms, and clinical analytics platform have the largest market shares in the total clinical trial IT solutions, and are estimated to touch $4,051.6 million in 2020.

Digital transformation is leading the clinical trial industry towards a data centric approach. The increasing volume and veracity of data that can be leveraged beyond traditional clinical data sets requires clinical trial IT systems to shift from fragmented application-centric IT systems to unified data-centric solutions.

Furthermore, the rising demand for quality data and novel endpoints demands CTDM solutions to migrate from point solutions that sit in silos to integrated eClinical solutions that provide a single source of truth, optimize costs by eliminating duplicate data entry, and reduce on-site verification and source data verification rate (SDVR).

This involves an evolving vendor ecosystem of modular, cloud-based eClinical solutions with intuitive user interface that is capable of integrating all possible study and eSource data to enhance clinical trial digital workflows and reduce data management cost and time.

Research Scope
The research service analyzes the top four growth opportunities in the global CTDM and emerging eClinical solutions. It also evaluates and discusses market projections, key trends, technology life cycle (adoption rate vs maturity), key implementation benefits, and challenges of top four CTDM and emerging eClinical solutions. Finally, it provides industry best practices, live case studies, cost benefit analysis, and strategic imperatives (call to action) for key clinical trial industry stakeholders such as pharma sponsors, CRO, sites, and technology providers.

Key Issues Addressed
• What are the key trends and growth opportunities that can be derived from the emerging digitally-led clinical trials operating models?
• Which technologies and IT systems (EDC, eSource, eCOA, RTSM) will have the strongest potential to optimize clinical workflows?
• What is the technology lifecycle for select clinical trials IT solutions (current adoption and future growth rates)?
• What are the gaps and inefficiencies in current CTDM workflows and how can these be filled by emerging clinical IT solutions?
• What does the new ecosystem of unified clinical IT systems/ eClinial solution providers look like?
• What are the key challenges while implementing these digital solutions across the clinical development value chain?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Rectal Cancer Global Clinical Trials Review, H2, 2019

Rectal Cancer Global Clinical Trials Review, H2, 2019

  • $ 2500
  • December 2019

Rectal Cancer Global Clinical Trials Review, H2, 2019Summaryclinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Rectal Cancer clinical trials scenario.This ...

Sarcopenia Global Clinical Trials Review, H2, 2019

Sarcopenia Global Clinical Trials Review, H2, 2019

  • $ 2500
  • December 2019

Sarcopenia Global Clinical Trials Review, H2, 2019Summaryclinical trial report, “Sarcopenia Global Clinical Trials Review, H2, 2019" provides an overview of Sarcopenia clinical trials scenario.This report ...

Febrile Neutropenia Global Clinical Trials Review, H2, 2019

Febrile Neutropenia Global Clinical Trials Review, H2, 2019

  • $ 2500
  • December 2019

Febrile Neutropenia Global Clinical Trials Review, H2, 2019Summaryclinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2019" provides an overview of Febrile Neutropenia clinical ...


ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on